{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:55:21Z","timestamp":1778028921367,"version":"3.51.4"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DA034231"],"award-info":[{"award-number":["R01 DA034231"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K02 DA027374"],"award-info":[{"award-number":["K02 DA027374"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DA033200"],"award-info":[{"award-number":["R01 DA033200"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 DA036154"],"award-info":[{"award-number":["R01 DA036154"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.mcn.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T19:06:23Z","timestamp":1421780783000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["GSK3\u03b2-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity"],"prefix":"10.1016","volume":"65","author":[{"given":"Ruturaj R.","family":"Masvekar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazira","family":"El-Hage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7886-0332","authenticated-orcid":false,"given":"Kurt F.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela E.","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2015.01.001_bb0005","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/emboj\/16.13.3797","article-title":"Beta-catenin is a target for the ubiquitin\u2013proteasome pathway","volume":"16","author":"Aberle","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.mcn.2015.01.001_bb0010","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1523\/JNEUROSCI.2733-07.2007","article-title":"Human immunodeficiency virus-1\/surface glycoprotein 120 induces apoptosis through RNA-activated protein kinase signaling in neurons","volume":"27","author":"Alirezaei","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.410400411","article-title":"HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease","volume":"40","author":"An","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004010051113","article-title":"Detection and localisation of HIV-1 DNA and RNA in fixed adult AIDS brain by polymerase chain reaction\/in situ hybridisation technique","volume":"98","author":"An","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0025","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/00005072-199911000-00005","article-title":"Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals","volume":"58","author":"An","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0030","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2741\/2762","article-title":"The effects of illicit drugs on the HIV infected brain","volume":"13","author":"Anthony","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0035","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awq263","article-title":"Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers","volume":"133","author":"Anthony","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.mcn.2015.01.001_bb0040","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.15-05-03328.1995","article-title":"Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord","volume":"15","author":"Arvidsson","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry","volume":"10","author":"Bagasra","year":"1996","journal-title":"AIDS"},{"issue":"Suppl. 2","key":"10.1016\/j.mcn.2015.01.001_bb0050","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/00126334-200210012-00003","article-title":"HIV and drug misuse in the Edinburgh cohort","volume":"31","author":"Bell","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.mcn.2015.01.001_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11481-006-9018-2","article-title":"Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs","volume":"1","author":"Bell","year":"2006","journal-title":"J. NeuroImmune Pharm."},{"key":"10.1016\/j.mcn.2015.01.001_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11481-005-9006-y","article-title":"Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease","volume":"1","author":"Bellizzi","year":"2006","journal-title":"J. NeuroImmune Pharm."},{"key":"10.1016\/j.mcn.2015.01.001_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/026988110001400304","article-title":"HIV dementia: the role of the basal ganglia and dopaminergic systems","volume":"14","author":"Berger","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000150539","article-title":"HIV dementia and the basal ganglia","volume":"40","author":"Berger","year":"1997","journal-title":"Intervirology"},{"key":"10.1016\/j.mcn.2015.01.001_bb0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/13550280902913628","article-title":"Morphine enhances Tat-induced activation in murine microglia","volume":"15","author":"Bokhari","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0080","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/glia.20708","article-title":"Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice","volume":"56","author":"Bruce-Keller","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.mcn.2015.01.001_bb0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0072-9752(07)85004-4","article-title":"The neuropathogenesis of HIV-1 infection","volume":"85","author":"Buescher","year":"2007","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0b013e318229ba41","article-title":"Neurocognitive impact of substance use in HIV infection","volume":"58","author":"Byrd","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.mcn.2015.01.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"Suppl.","key":"10.1016\/j.mcn.2015.01.001_bb0100","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1002\/ana.410230716","article-title":"Distinct biological and serological properties of human immunodeficiency viruses from the brain","volume":"23","author":"Cheng-Mayer","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0105","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/ijms10031045","article-title":"Molecular pathology of neuro-AIDS (CNS-HIV)","volume":"10","author":"Crews","year":"2009","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11065-009-9092-3","article-title":"Neuropsychological functioning and antiretroviral treatment in HIV\/AIDS: a review","volume":"19","author":"Cysique","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.mcn.2015.01.001_bb0120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/13550280490521078","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0125","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.01.001_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11481-006-9051-1","article-title":"Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS","volume":"2","author":"Dewhurst","year":"2007","journal-title":"J. NeuroImmune Pharm."},{"key":"10.1016\/j.mcn.2015.01.001_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2010.08.084","article-title":"Valproate attenuates the development of morphine antinociceptive tolerance","volume":"485","author":"Dobashi","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.mcn.2015.01.001_bb0140","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1097\/00002030-200307040-00015","article-title":"Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy","volume":"17","author":"Dore","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.mcn.2015.01.001_bb0145","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1523\/JNEUROSCI.23-27-09162.2003","article-title":"Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis","volume":"23","author":"Dou","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0150","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1523\/JNEUROSCI.2164-05.2005","article-title":"Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis","volume":"25","author":"Dou","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/glia.20148","article-title":"Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat","volume":"50","author":"El-Hage","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.mcn.2015.01.001_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrn2040","article-title":"HIV and antiretroviral therapy in the brain: neuronal injury and repair","volume":"8","author":"Ellis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0165","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","article-title":"Convergent evidence for impaired AKT1\u2013GSK3beta signaling in schizophrenia","volume":"36","author":"Emamian","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2015.01.001_bb0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.410330502","article-title":"Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms","volume":"33","author":"Epstein","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1750-3639.1999.tb00219.x","article-title":"Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center","volume":"9","author":"Everall","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0180","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/mcne.2002.1196","article-title":"Lithium ameliorates HIV-gp120-mediated neurotoxicity","volume":"21","author":"Everall","year":"2002","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399405010239","article-title":"Evolving paradigms in the pathogenesis of HIV-1-associated dementia","volume":"7","author":"Fischer-Smith","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.mcn.2015.01.001_bb0190","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2353\/ajpath.2010.090945","article-title":"Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons","volume":"177","author":"Fitting","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0195","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/pr900926n","article-title":"Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis","volume":"9","author":"Fitting","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.mcn.2015.01.001_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3590001","article-title":"GSK3 takes centre stage more than 20years after its discovery","volume":"359","author":"Frame","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.mcn.2015.01.001_bb0205","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S1097-2765(01)00253-2","article-title":"A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation","volume":"7","author":"Frame","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mcn.2015.01.001_bb0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","author":"Gonzalez-Scarano","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0220","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0306-4522(00)00461-9","article-title":"Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro","volume":"102","author":"Gurwell","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2015.01.001_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2013.12.008","article-title":"Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3beta signaling in bipolar patients","volume":"156","author":"Haenisch","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.mcn.2015.01.001_bb0230","doi-asserted-by":"crossref","first-page":"21395","DOI":"10.1074\/jbc.274.30.21395","article-title":"Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent pathway","volume":"274","author":"Hartigan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.01.001_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03033820","article-title":"Molecular targets of opiate drug abuse in neuroAIDS","volume":"8","author":"Hauser","year":"2005","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.mcn.2015.01.001_bb0240","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0028-3908(02)00030-8","article-title":"Morphine induces apoptosis of human microglia and neurons","volume":"42","author":"Hu","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2015.01.001_bb0245","doi-asserted-by":"crossref","first-page":"38415","DOI":"10.1074\/jbc.M110.109827","article-title":"Morphine modulation of thrombospondin levels in astrocytes and its implications for neurite outgrowth and synapse formation","volume":"285","author":"Ikeda","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.01.001_bb0250","doi-asserted-by":"crossref","first-page":"930710","DOI":"10.1155\/2012\/930710","article-title":"GSK-3beta: a bifunctional role in cell death pathways","volume":"2012","author":"Jacobs","year":"2012","journal-title":"Int. J. Cell Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.mcn.2015.01.001_bb0255","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","article-title":"HIV-1 infection and AIDS: consequences for the central nervous system","volume":"12","author":"Kaul","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.mcn.2015.01.001_bb0260","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0959-4388(02)00320-3","article-title":"The GSK3 beta signaling cascade and neurodegenerative disease","volume":"12","author":"Kaytor","year":"2002","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0265","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/13550289909021992","article-title":"CNS as an HIV-1 reservoir; BBB and drug delivery","volume":"5","author":"Kerza-Kwiatecki","year":"1999","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0270","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1523\/JNEUROSCI.2958-08.2008","article-title":"Human immunodeficiency virus protein Tat induces synapse loss via a reversible process that is distinct from cell death","volume":"28","author":"Kim","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0275","doi-asserted-by":"crossref","first-page":"129753","DOI":"10.4061\/2011\/129753","article-title":"Glycogen synthase kinase-3beta: a mediator of inflammation in Alzheimer's disease?","volume":"2011","author":"Koistinaho","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.mcn.2015.01.001_bb0280","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cmdc.200500039","article-title":"Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease","volume":"1","author":"Kozikowski","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.mcn.2015.01.001_bb0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virusres.2005.04.009","article-title":"Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus","volume":"111","author":"Kramer-Hammerle","year":"2005","journal-title":"Virus Res."},{"key":"10.1016\/j.mcn.2015.01.001_bb0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0295","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2009.11.074","article-title":"Toll-like receptor 2 is required for opioids-induced neuronal apoptosis","volume":"391","author":"Li","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcn.2015.01.001_bb0300","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1471-4159.1999.0730578.x","article-title":"HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity","volume":"73","author":"Maggirwar","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2015.01.001_bb0305","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0166-2236(95)93946-U","article-title":"Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications","volume":"18","author":"Mansour","year":"1995","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0315","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.410420618","article-title":"Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center","volume":"42","author":"Masliah","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0320","doi-asserted-by":"crossref","first-page":"e100196","DOI":"10.1371\/journal.pone.0100196","article-title":"Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neurites","volume":"9","author":"Masvekar","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mcn.2015.01.001_bb0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","article-title":"HIV dementia: an evolving disease","volume":"157","author":"McArthur","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0330","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13550280390194109","article-title":"Human immunodeficiency virus-associated dementia: an evolving disease","volume":"9","author":"McArthur","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0335","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","article-title":"Neurological complications of HIV infection","volume":"4","author":"McArthur","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0340","doi-asserted-by":"crossref","first-page":"18844","DOI":"10.7448\/IAS.17.1.18844","article-title":"Injecting drug use is associated with a more rapid CD4 cell decline among treatment naive HIV-positive patients in Indonesia","volume":"17","author":"Meijerink","year":"2014","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.mcn.2015.01.001_bb0345","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1471-4159.2009.06156.x","article-title":"Inhibition of EGF-induced ERK\/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways","volume":"110","author":"Miyatake","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2015.01.001_bb0350","article-title":"Eradication of human immunodeficiency virus from brain reservoirs","author":"Nath","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0355","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3565(25)22252-2","article-title":"Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients","volume":"250","author":"Novick","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mcn.2015.01.001_bb0360","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11481-013-9454-8","article-title":"Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration","volume":"8","author":"Pang","year":"2013","journal-title":"J. NeuroImmune Pharm."},{"key":"10.1016\/j.mcn.2015.01.001_bb0365","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1124\/jpet.106.107581","article-title":"Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats","volume":"319","author":"Parkitna","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mcn.2015.01.001_bb0370","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.ajpath.2010.12.033","article-title":"Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with roscovitine","volume":"178","author":"Patrick","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0375","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00002030-199009000-00006","article-title":"Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures","volume":"4","author":"Peterson","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/j.mcn.2015.01.001_bb0380","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-2980-4_26","article-title":"Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection","volume":"335","author":"Peterson","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0385","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2003.10.026","article-title":"Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures","volume":"147","author":"Peterson","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0390","first-page":"147","article-title":"Glycogen synthase kinase-3: functions in oncogenesis and development","volume":"1114","author":"Plyte","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2015.01.001_bb0395","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11481-011-9326-z","article-title":"Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain","volume":"7","author":"Podhaizer","year":"2012","journal-title":"J. NeuroImmune Pharm."},{"key":"10.1016\/j.mcn.2015.01.001_bb0400","doi-asserted-by":"crossref","first-page":"23534","DOI":"10.1074\/jbc.273.36.23534","article-title":"\u03bc-Opioid receptor activates signaling pathways implicated in cell survival and translational control","volume":"273","author":"Polakiewicz","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2015.01.001_bb0405","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.302.3.1002","article-title":"Differential effects of mu-opioid receptor ligands on Ca(2+) signaling","volume":"302","author":"Quillan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mcn.2015.01.001_bb0410","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2990.2005.00670.x","article-title":"Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers","volume":"31","author":"Ramage","year":"2005","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0415","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/bmj.309.6951.369","article-title":"Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10years","volume":"309","author":"Robertson","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.mcn.2015.01.001_bb0420","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.mcn.2015.01.001_bb0425","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s11904-009-0020-1","article-title":"HIV-related neurocognitive impairment in the HAART era","volume":"6","author":"Robinson-Papp","year":"2009","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.mcn.2015.01.001_bb0430","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/mus.23231","article-title":"Substance abuse increases the risk of neuropathy in an HIV-infected cohort","volume":"45","author":"Robinson-Papp","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.mcn.2015.01.001_bb0435","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1471-4906(03)00003-6","article-title":"Opioid G protein-coupled receptors: signals at the crossroads of inflammation","volume":"24","author":"Rogers","year":"2003","journal-title":"Trends Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.mcn.2015.01.001_bb0440","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13550280290101094","article-title":"The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0445","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/y86-001","article-title":"The therapeutic use of heroin: a review of the pharmacological literature","volume":"64","author":"Sawynok","year":"1986","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0455","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archneur.65.10.1368","article-title":"Association of GSK3B with Alzheimer disease and frontotemporal dementia","volume":"65","author":"Schaffer","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0460","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","article-title":"Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report","volume":"66","author":"Schifitto","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2015.01.001_bb0465","first-page":"359","article-title":"Immunomodulatory role of opioids in the central nervous system","volume":"45","author":"Sheng","year":"1997","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.mcn.2015.01.001_bb0470","first-page":"387","article-title":"Dendritic organization in the neurons of the visual and motor cortices of the cat","volume":"87","author":"Sholl","year":"1953","journal-title":"J. Anat."},{"key":"10.1016\/j.mcn.2015.01.001_bb0475","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/13550280490441103","article-title":"Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: differential involvement of caspase-3 and endonuclease G","volume":"10","author":"Singh","year":"2004","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0480","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s13365-013-0225-3","article-title":"Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users","volume":"20","author":"Smith","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0485","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1098-1136(199803)22:3<249::AID-GLIA4>3.0.CO;2-0","article-title":"Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes","volume":"22","author":"Stiene-Martin","year":"1998","journal-title":"Glia"},{"key":"10.1016\/j.mcn.2015.01.001_bb0490","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/j.1460-9568.2006.04813.x","article-title":"Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons","volume":"23","author":"Sui","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.mcn.2015.01.001_bb0495","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1750-1326-6-78","article-title":"Fractalkine\/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death","volume":"6","author":"Suzuki","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.mcn.2015.01.001_bb0500","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410390606","article-title":"Localization of HIV-1 in human brain using polymerase chain reaction\/in situ hybridization and immunocytochemistry","volume":"39","author":"Takahashi","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0505","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/jnr.21653","article-title":"Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia","volume":"86","author":"Turchan-Cholewo","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2015.01.001_bb0510","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1471-4159.2007.04746.x","article-title":"Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity","volume":"103","author":"Wang","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2015.01.001_bb0515","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neuropharm.2010.06.006","article-title":"Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis","volume":"59","author":"Xie","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2015.01.001_bb0520","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s13365-010-0016-z","article-title":"PTEN gene silencing prevents HIV-1 gp120(IIIB)-induced degeneration of striatal neurons","volume":"17","author":"Zou","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.mcn.2015.01.001_bb0525","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/brain\/awr281","article-title":"Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at mu-opioid receptor-expressing glia","volume":"134","author":"Zou","year":"2011","journal-title":"Brain"}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743115000032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743115000032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:21:48Z","timestamp":1747466508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743115000032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":105,"alternative-id":["S1044743115000032"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2015.01.001","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GSK3\u03b2-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}